Research Article
Volume 11 Issue 11 - 2020
A Comparative Study Determining the Efficacy of Intravenous Versus Topical Tranexamic Acid Administration in Total Knee Arthroplasty
Ahsan Javaid Butt, Fares Uddin, Yousaf Alkhalfan, Muhammad Zain-ur-Rehman*, Salman Langawi and Hesham Alkhateeb
King Hamad University Hospital, Kingdom of Bahrain
*Corresponding Author: Muhammad Zain-ur-Rehman, Specialist Registrar, King Hamad University Hospital, Kingdom of Bahrain.
Received: September 16, 2020; Published: October 30, 2020




Abstract

Introduction: Total knee replacements are one of the most common Orthopaedic procedures performed worldwide and the numbers are rising at exponential rates. Blood loss is a significant concern among the population in which it is commonly performed, infrequently necessitating blood transfusion. The use of tranexamic acid (TXA) has been shown to be efficacious in reducing perioperative bleeding as well as subsequent transfusion rates by multiple meta analyses. But the efficacy and safety of one route of administration over the other are yet to be clearly defined.

Methodology: We present a retrospective cohort study evaluating intravenous (IV) versus topical TXA administration among 120 patients undergoing total knee replacements at a single centre using similar implants and surgical techniques.

Results and Discussion: The mean drop in haemoglobin postoperatively was 0.93 g/dL and 0.89 g/dL in the topical and intravenous groups respectively. These were not found to be statistically significant. No difference was found when assessing for average length of stay, transfusion rates, thromboembolic events, infection and mortality.

Several randomized control trials have demonstrated equal efficacy of topical tranexamic acid administration compared to topical when evaluating for blood loss, transfusion rates, and thromboembolic events. Although topical administration may not be able to achieve optimal therapeutic levels in the local tissues - this has not demonstrably translated into clinical findings. the evidence suggests that the use of topical TXA is superior to its IV counterpart in reducing the overall hospital cost per total knee arthroplasty whilst being equally efficacious in reducing the need for blood transfusions.

Conclusion: Our study demonstrates similar outcomes between IV and topical TXA administration with no reported adverse events. Further studies are needed to establish the ideal dosing, delivery method and whether additional therapeutic agents can further help improve outcomes following total knee arthroplasty.

Keywords: Total Knee Arthroplasty; Total Knee Replacement; Blood Loss; Tranexamic Acid      

References

  1. Agency for Healthcare Research and Quality HCU Pnet. National and regional estimates on hospital use for all patients from the HCUP Nationwide Inpatient sample (NIS) (2007).
  2. Dillon CF., et al. “Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94”. The Journal of Rheumatology 33 (2006): 2271-2279.
  3. Bong MR., et al. “Risks associated with blood transfusion after total knee arthroplasty”. The Journal of Arthroplasty 19 (2004): 281-287.
  4. Bierbaum BE., et al. “An analysis of blood management in patients having a total hip or knee arthroplasty”. Journal of Bone and Joint Surgery American 81 (1999): 2-10.
  5. Lanes SF., et al. “Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs”. Arthritis and Rheumatology 40 (1997): 1475-1481.
  6. Sehat KR., et al. “Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into ac- count”. The Journal of Bone and Joint Surgery British 86 (2004): 561-565.
  7. Kalairajah Y., et al. “Blood loss after total knee replacement: effects of computer-assisted surgery”. The Journal of Bone and Joint Surgery British 87 (2005): 1480-1482.
  8. Risberg B. “The response of the fibrinolytic system in trauma”. Acta Chirurgica Scandinavica 522 (1985): 245-271.
  9. Benoni G., et al. “The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty”. Thrombosis Research 85 (1997): 195-206.
  10. Zufferey P., et al. “Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?” Anesthesiology 105 (2006): 1034-1046.
  11. Cid J and Lozano M. “Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials”. Transfusion 45 (2005): 1302-1307.
  12. Kagoma YK., et al. “Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials”. Thrombosis Research 123 (2009): 687-696.
  13. Wong J., et al. “Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial”. Journal of Bone and Joint Surgery American 15 (2010): 2503-2513.
  14. Georgiadis AG., et al. “A prospective double- blind placebo-controlled trial of topical tranexamic acid in total knee arthroplasty”. The Journal of Arthroplasty 8 (2013): 78-82.
  15. Ishida K., et al. “Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty”. International Orthopaedics 11 (2011): 1639-1645.
  16. Martin JG., et al. “Topical administration of tranexamic acid in primary total hip and total knee arthroplasty”. The Journal of Arthroplasty 5 (2014): 889-894.
  17. Meena S., et al. “Topical versus intravenous tranexamic acid in total knee arthroplasty”. Journal of Orthopaedic Surgery (2017): 1.
  18. Tzatzairis TK., et al. “Intravenous vs Topical Tranexamic Acid in Total Knee Arthroplasty Without Tourniquet Application: A Randomized Controlled Study”. The Journal of Arthroplasty 11 (2016): 2465-2470.
  19. Patel JN., et al. “Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study”. The Journal of Arthroplasty 8 (2014): 1528-1531.
  20. Hamlin BR., et al. “Topical versus intravenous tranexamic acid in total knee arthroplasty”. The Journal of Arthroplasty 3 (2015): 384-386.
  21. Seo JG., et al. “The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty”. Knee Surgery, Sports Traumatology, Arthroscopy 8 (2013): 1869-1874.
  22. Huang Z., et al. “Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial”. The Journal of Arthroplasty 12 (2014): 2342-2346.
  23. Nilsson IM. “Clinical pharmacology of aminocaproic and tranexamic acids”. Journal of Clinical Pathology 14 (1980): 41-47.
  24. Ahlberg A., et al. “Diffusion of tranexamic acid to the joint”. Acta Orthopaedica Scandinavica 47 (1967): 486-488.
  25. Dunn CJ and Goa KL. “Tranexamic acid: a review of its use in surgery and other indications”. Drugs 57 (1999): 1005-1032.
  26. Alshryda S., et al. “Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K)”. Journal of Bone and Joint Surgery American 21 (2013): 1961-1968.
  27. Chimento GF., et al. “An evaluation of the use of topical tranexamic acid in total knee arthroplasty”. The Journal of Arthroplasty 8 (2013): 74-77.
  28. Moskal JT., et al. “Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012”. The Journal of Arthroplasty 3 (2015): 365-368.
Citation: Muhammad Zain-ur-Rehman., et al. “A Comparative Study Determining the Efficacy of Intravenous Versus Topical Tranexamic Acid Administration in Total Knee Arthroplasty”.EC Orthopaedics 11.11 (2020): 51-58.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.